Middle East & Africa Respiratory Inhalers Market

The Middle East & Africa respiratory inhalers market is expected to grow from US$ 1,541.66 million in 2022 to US$ 2,050.66 million by 2028. It is estimated to register a CAGR of 4.9% from 2022 to 2028. 

Increasing Adoption of Smart Inhalers Technology is Fueling Middle East & Africa Respiratory Inhalers Market  

Smart inhalers aim to help people suffering from asthma ensure they take their medication as prescribed by recording the timing and dosage on their smartphones. The data collected can be used by a clinician to verify that the prescribed treatment is working, personalize asthma reviews to focus on the root causes of worsening symptoms, and provide early warning systems that inform when to visit a clinic. This technology could shift from one-size-fits-all asthma screening and lead to fewer routine appointments. Smart inhalers benefit adults and the geriatric population, as they struggle to take the same puffs due to uneven breathing as the muscles that support breathing and the diaphragm weaken with age, preventing air from inhaling or exhaling. Smart inhalers that are equipped with sensors can be connected to conventional inhalers and help to keep track of when the medication is taken. Being Bluetooth-enabled, they can also be remotely paired with a computer or smart device, such as a phone or tablet, to transfer data from the smart inhaler automatically. Therefore, the above-mentioned applications of smart inhalers and their growing adoption are expected to provide growth opportunities to the respiratory inhalers market in the coming years.

Middle East & Africa Respiratory Inhalers Market Overview

The Middle East & Africa respiratory inhalers market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Saudi Arabia dominated the Middle East & Africa respiratory inhalers market in 2022. The market is driven by a vast population base and an increase in the prevalence of respiratory diseases. The government of Saudi Arabia is promoting and offering several incentives for the domestic manufacturing of medical devices, which can drive the overall market in this country. As per the study conducted by Boehringer Ingelheim in 2018, there were more than 7,800 people with COPD in Saudi Arabia. COPD prevalence is booming in Saudi Arabia because of the rapidly expanding cases of smoking among the population. The prevalence of COPD in the Kingdom is 2.4%. In addition, the burden of asthma in Saudi Arabia is rising as the overall prevalence of asthma in children from Saudi Arabia has been reported to range from 8% to 25% based on studies conducted over the past three decades. Hence, the increasing prevalence of chronic respiratory diseases is leading the market’s growth.  

Middle East & Africa Respiratory Inhalers Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Respiratory Inhalers Strategic Insights

Strategic insights for the Middle East & Africa Respiratory Inhalers provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa Respiratory Inhalers Report Scope

Middle East & Africa Respiratory Inhalers Regional Insights

The geographic scope of the Middle East & Africa Respiratory Inhalers refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa Respiratory Inhalers Market Segmentation

The Middle East & Africa respiratory inhalers market is segmented based on product type, technology, disease indication, and country.

Based on product type, the Middle East & Africa respiratory inhalers market is segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment held the largest share of the Middle East & Africa respiratory inhalers market in 2022.

Based on technology, the Middle East & Africa respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger share of the Middle East & Africa respiratory inhalers market in 2022.

Based on disease indication, the Middle East & Africa respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the Middle East & Africa respiratory inhalers market in 2022.   

Based on country, the Middle East & Africa respiratory inhalers market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa respiratory inhalers market in 2022.

AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd; GSK Plc; Koninklijke Philips NV; OMRON Corp; OPKO Health, Inc; PARI Respiratory Equipment, Inc.; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the Middle East & Africa respiratory inhalers market.